News and Trends 22 Jan 2018
New Triple Combination Therapy Boosts Colorectal Cancer Survival
Pierre Fabre and Array BioPharma's combination therapy for colorectal cancer has improved progression-free survival in a Phase III trial. French pharma Pierre Fabre and American biopharma Array BioPharma, has carried out…